Decomplexation of the trivalent lanthanide, Ln(III), from the racemic bimetallic triple-stranded helicates [LnCr(L8)(3)](6+) provides the inert chiral tripodal nonadentate receptor [Cr(L8)(3)](3+). Elution of the latter podand with Na(2)Sb(2)[(+)-C(4)O(6)H(2)](2).5H(2)O through a cation exchange column allows its separation into its inert helical enantiomers M-(+)(589)-[Cr(L8)(3)](3+) and P-(-)(589)-[Cr(L8)(3)](3+), whose absolute configurations are assigned by using CD spectroscopy and exciton theory. Recombination with Ln(III) restores the original triple-stranded helicates [LnCr(L8)(3)](6+), and the associated thermodynamic parameters unravel the contribution of electrostatic repulsion and preorganization to the complexation process. Combining M-(+)(589)-[Cr(L8)(3)](3+) with Eu(III) produces the enantiomerically pure d-f helicate MM-(-)(589)-[EuCr(L8)(3)](CF(3)SO(3))(6).4CH(3)CN, whose X-ray crystal structure (EuCrC(113)H(111)N(25)O(21)S(6)F(18), monoclinic, P2(1), Z = 2) unambiguously confirms the absolute left-handed configuration for the final helix. The associated ligand-centered and metal-centered chiro-optical properties recorded for the complexes MM-[LnCr(L8)(3)](6+) and PP-[LnCr(L8)(3)](6+) (Ln = Eu, Gd, Tb) show a strong effect of helicity on specific rotary dispersions, CD and CPL spectra.
No takes yet. Share an insight, caveat, or question.
Cantuel et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: